crossbeta.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: /wordpress/wp-admin/ Allow: /wordpress/wp-admin/admin-ajax.php # START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.crossbeta.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Home -
Description Crossbeta Crossbeta Biosciences has developed an innovative technology to generate stable oligomers for drug discovery and development in disease areas characterized by the presence of misfolded
Keywords N/A
Server Information
WebSite crossbeta faviconcrossbeta.com
Host IP 83.96.176.80
Location Netherlands
Related Websites
Site Rank
More to Explore
crossbeta.com Valuation
US$558,181
Last updated: 2023-05-07 18:24:12

crossbeta.com has Semrush global rank of 18,962,157. crossbeta.com has an estimated worth of US$ 558,181, based on its estimated Ads revenue. crossbeta.com receives approximately 64,406 unique visitors each day. Its web server is located in Netherlands, with IP address 83.96.176.80. According to SiteAdvisor, crossbeta.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$558,181
Daily Ads Revenue US$516
Monthly Ads Revenue US$15,458
Yearly Ads Revenue US$185,488
Daily Unique Visitors 4,294
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
crossbeta.com. A 86397 IP: 83.96.176.80
crossbeta.com. NS 86400 NS Record: ns2.dds.eu.
crossbeta.com. NS 86400 NS Record: ns3.dds.amsterdam.
crossbeta.com. NS 86400 NS Record: ns1.dds.nl.
crossbeta.com. MX 300 MX Record: 0 crossbeta-com.mail.protection.outlook.com.
crossbeta.com. TXT 300 TXT Record: MS=ms81531302
crossbeta.com. TXT 300 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-07 18:24:12
Crossbeta Biosciences NOVEL APPROACHES FOR TREATING AGE-RELATED DISEASES Crossbeta Biosciences is a biotech company with a focus on Alzheimer’s and Parkinson’s disease. For both indications we have developed novel immunotherapy candidates targeting the toxic oligomers implicated in these pathologies. Our Alzheimer program has been spun out into DegenRx and our Parkinson program is transferred to Syngle Therapeutics . Further information regarding DegenRx and Syngle Therapeutics and their drug development activities can be found on their respective websites. Crossbeta Biosciences BV PO Box 13283 3507 LG Utrecht The Netherlands g.scheefhals@crossbeta.com Crossbeta Proudly powered by WordPress
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Thu, 28 Oct 2021 12:57:19 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Powered-By: PHP/7.4.24
X-Redirect-By: WordPress
Location: http://www.crossbeta.com/

HTTP/1.1 200 OK
Server: nginx
Date: Thu, 28 Oct 2021 12:57:20 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Powered-By: PHP/7.4.24
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
crossbeta.com Whois Information
Domain Name: CROSSBETA.COM
Registry Domain ID: 184976576_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.PublicDomainRegistry.com
Registrar URL: http://www.publicdomainregistry.com
Updated Date: 2021-07-08T12:18:03Z
Creation Date: 2005-07-18T11:18:43Z
Registry Expiry Date: 2022-07-18T11:18:43Z
Registrar: PDR Ltd. d/b/a PublicDomainRegistry.com
Registrar IANA ID: 303
Registrar Abuse Contact Email: abuse-contact@publicdomainregistry.com
Registrar Abuse Contact Phone: +1.2013775952
Domain Status: ok https://icann.org/epp#ok
Name Server: NS1.DDS.NL
Name Server: NS2.DDS.EU
Name Server: NS3.DDS.AMSTERDAM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-16T05:23:07Z <<<

Copyright © 2022 WebZZ.US 0.0190